Karuna Pharmaceuticals' Debt Round

Karuna Pharmaceuticals raised a round of funding on June 09, 2011.

Karuna is a clinical-stage drug development company targeting muscarinic receptors for the treatment of psychosis and cognition across central nervous system (CNS) disorders, including schizophrenia a…

Articles about Karuna Pharmaceuticals' Debt Round: